Analysis of tumor-associated antigen expressions and immune responses using clinical samples

Analysis of tumor-associated antigen expressions and immune responses using clinical samples - Analysis of tumor-antigen expressions and immune responses

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032851

Enrollment

120

Registered

2018-06-04

Start date

2018-06-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumors, healthy volunteers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient having malignant tuomors (including esophageal cancer, gastric cancer, colon cancer, gynecological cancer, head/neck cancer, urological cancer, bone and soft tissue cancer, and hematological malignancy, et al), who is aged 12 years or older Healthy volunteer as a control, who is aged 20 years or older

Exclusion criteria

Exclusion criteria: No obtaining an informed consent

Design outcomes

Primary

Measure	Time frame
Tumor antigen expressions immune responses in peripheral blood and tumor sites(in possible cases)	—

Countries

Japan

Contacts

Public ContactYoshihiro Miyahara

Mie University Graduate School of Medicine Personalized Cancer Immunotherapy

miyahr-y@med.mie-u.ac.jp059-231-5684

Outcome results